[go: up one dir, main page]

EP1648396A2 - Hautschutzmittel - Google Patents

Hautschutzmittel

Info

Publication number
EP1648396A2
EP1648396A2 EP04742820A EP04742820A EP1648396A2 EP 1648396 A2 EP1648396 A2 EP 1648396A2 EP 04742820 A EP04742820 A EP 04742820A EP 04742820 A EP04742820 A EP 04742820A EP 1648396 A2 EP1648396 A2 EP 1648396A2
Authority
EP
European Patent Office
Prior art keywords
product
fenugreek
epidermis
protective product
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP04742820A
Other languages
English (en)
French (fr)
Inventor
Maité BRUNEAUD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ninapharm (sarl)
Original Assignee
Ninapharm (sarl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ninapharm (sarl) filed Critical Ninapharm (sarl)
Publication of EP1648396A2 publication Critical patent/EP1648396A2/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Definitions

  • the present invention relates to a product for protecting the epidermis. It relates more particularly to a product allowing reinforced protection of the epidermis, which is based on the association of Nano Active Receptors (NAR) derived from Fenugreek
  • the present invention provides a new product, intended to be used for nutraceutical and cosmetic applications, which allows enhanced protection of the epidermis.
  • the active ingredient is isolated in a membrane composed of bioactive ingredients which provide the guiding role for the release of the active agents on a given target.
  • the product uses the same molecular structure as Fenugreek to release its active ingredients.
  • Fenugreek is made up of Nano-Receptive Receptacles that Engineers have isolated. Said product therefore makes it possible to release the active agents on a given target with great precision and increased efficiency, identical to the molecular structure of Fenugreek.
  • the Fenugreek Isolated Receiver Nanos are incorporated into the lipid membrane, as illustrated in Figure 1, on which we find inside the microcapsule (1), the active (2) and the nano active receptors isolated from Fenugreek (3) in the membrane.
  • the invention thus used protects the activity of the active ingredients and allows their release on the areas hitherto never reached by conventional active ingredients.
  • the product is composed of hollow microspheres formed of lipid bilayers whose membrane is made up of phospholipids and bioactive ingredients: NARs (Nano Active Receptors) from Fenugreek.
  • NARs Nano Active Receptors
  • the characteristics of the liposomes of the invention can be modified.
  • its composition and its size are modified.
  • the affinity of the product is increased by modifying its composition, its electrical charge or by adding receptors or adhesion factors.
  • the product of the invention protects the skin from the inside and from the outside (nutraceutical and cosmetic application).
  • the vitamin and mineral intake decreases and leads to oxidation.
  • the skin needs external and internal intakes of vitamins, fatty acids and antioxidants.
  • the invention makes it possible to penetrate the different layers of the epidermis and to repair lesions with precision.
  • Skin lesions are treated and the skin is rejuvenated from the inside and outside.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP04742820A 2003-05-23 2004-05-22 Hautschutzmittel Ceased EP1648396A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0306552 2003-05-23
PCT/FR2004/001282 WO2004105719A2 (fr) 2003-05-23 2004-05-22 Produit destine a la protection de l’epiderme

Publications (1)

Publication Number Publication Date
EP1648396A2 true EP1648396A2 (de) 2006-04-26

Family

ID=33484286

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04742820A Ceased EP1648396A2 (de) 2003-05-23 2004-05-22 Hautschutzmittel

Country Status (2)

Country Link
EP (1) EP1648396A2 (de)
WO (1) WO2004105719A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3031669B1 (fr) * 2015-01-19 2020-01-31 Ninapharm Systeme de delivrance avancee (ads)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196190A (en) * 1990-10-03 1993-03-23 Zenith Technology Corporation, Limited Synthetic skin substitutes
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
IL122776A (en) * 1997-12-28 2004-07-25 Dead Sea Lab Ltd Gel composition for skin care and protection and a method for preparation thereof
AU7989100A (en) * 1999-10-01 2001-05-10 Acrymed Silver-containing compositions, devices and methods for making
FR2803513B1 (fr) * 2000-01-12 2003-12-19 Oreal Utilisation de la dhea et/ou de ses precurseurs ou derives pour ameliorer l'aspect papyrace de la peau
FR2827765B1 (fr) * 2001-07-27 2003-09-19 Oreal Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004105719A2 *

Also Published As

Publication number Publication date
WO2004105719A2 (fr) 2004-12-09
WO2004105719A3 (fr) 2005-04-07

Similar Documents

Publication Publication Date Title
EP1443898B1 (de) Mittel enthaltend ein rote algen extrakt der gattung porphyra und ihre verwendung zum schutz der zellen
AU2008337269B2 (en) Formulations comprising exine shells
AU2006273841B2 (en) Uses of sporopollenin
São Pedro et al. Chitosan: an option for development of essential oil delivery systems for oral cavity care?
Shi et al. Stabilization and encapsulation of photosensitive resveratrol within yeast cell
TW200908891A (en) Microencapsulating compositions, methods of making, methods of using and products thereof
Sarabandi et al. Fractionation of flaxseed-derived bioactive peptides and their influence on nanoliposomal carriers
EP2911680B1 (de) Verwendung eines flachsextraktes aus der hydrolyse von flachsproteinen als aktives antimikrobielles mittel
Paiva-Santos et al. Nanotechnology-based formulations toward the improved topical delivery of anti-acne active ingredients
EP2293783B1 (de) Gebleichte exine
EP1648396A2 (de) Hautschutzmittel
EP2419439B1 (de) Ein linderndes peptidisches hydrolysat enthaltende kosmetische und/oder pharmazeutische zusammensetzung
FR2556218A1 (fr) Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique
CA2426284A1 (fr) Composition anti-adipeuse a base d'extraits de bulbes d'ail
KR101779671B1 (ko) 사카로미세스속 효모 추출물을 포함하는 천연 리포좀, 그 제조방법 및 이를 포함하는 식품 또는 약학 조성물
EP1480610B1 (de) Verwendung einer hsp induzierenden verbindung zur begrenzung sekundärer wirkungen von retinoiden
WO2004096172A2 (fr) Vecteur pour administration par voie orale
FR3015278A1 (fr) Macerat huileux de patiron ( cucurbita maxima ) pour un usage cosmetique
FR2832628A1 (fr) Un produit a base d'extrait d'algue rouge du genre porphyra, sa preparation et ses utilisations pour proteger les cellules
Palshetkar et al. Topical drug delivery for psoriasis using nanocarriers
FR3049462A1 (fr) Utilisation d'extraits de bacteries deinococcus comme agents cosmetiques ou pharmaceutiques
FR3018685B1 (fr) Applications cosmetiques et pharmaceutiques de la salicaire
CN116019778A (zh) 牡丹花蕊复合微晶囊体组合物的制作方法及其抗蓝光、保护细胞、抗过敏、与抗老化的用途
FR2835745A1 (fr) Composition cosmetique ou pharmaceutique comprenant un inducteur de hsp et des retinoides, procede de traitement et utilisation
FR2977799A1 (fr) Utilisation de surnageants de culture de micro-algues pour leurs proprietes antibacteriennes, notamment dans le traitement des infection cutanees

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051214

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20060725

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APAZ Date of receipt of statement of grounds of appeal deleted

Free format text: ORIGINAL CODE: EPIDOSDNOA3E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAV Appeal reference deleted

Free format text: ORIGINAL CODE: EPIDOSDREFNE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20140722